Chinmoy K. Bose
16A Park Lane
Kolkata, WB, India
Kolkata, WB, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer.
Journal: Journal of gynecologic oncology
Published: November 20, 2023
Controversy of tissue-agnostic approvals in immunotherapy and targeted therapy.
Journal: Medical oncology (Northwood, London, England)
Published: January 12, 2022
Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer.
Journal: Medical oncology (Northwood, London, England)
Published: October 26, 2021
Interplay of gut microbiome, fatty acids, and the endocannabinoid system in regulating development, progression, immunomodulation, and chemoresistance of cancer.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: August 05, 2021
Determinants of lymph node status in women with breast cancer: A hospital based study from eastern India.
Journal: The Indian journal of medical research
Published: October 18, 2016
Emil "Tom" Frei III, MD (1924-2013).
Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
Published: July 10, 2014
Anomalous endocrine feedback of peri-menopause in the etiology of type II ovarian cancer.
Journal: Future oncology (London, England)
Published: August 29, 2013
Follicle stimulating hormone receptor in ovarian surface epithelium and epithelial ovarian cancer.
Journal: Oncology research
Published: November 05, 2008
Follicle stimulating hormone receptor (FSHR) antagonist and epithelial ovarian cancer (EOC).
Journal: Journal of experimental therapeutics & oncology
Published: June 08, 2007
Does hormone replacement therapy prevent epithelial ovarian cancer?
Journal: Reproductive biomedicine online
Published: August 17, 2005
Showing 1-11 of 11
Last Updated: 09/26/2026